|
|
Post by fldave007 on Feb 21, 2017 11:53:45 GMT -5
Nothing is going to move sales until we start a series of hard hitting advertisements. The pic of the kid that looks like a human pin cushion would be excellent. Look it is a new ballgame and consumers will have to drive demand the a'hole endo's will not, face it and move on. The ads will have to be made with the consumer in mind it should not be rocket science. Take the 30 million loan available and get started with the ads. Concentrate on selected areas and have sales dept follow up. The time is now. Management you are killing us using your old school methods they don't work get moving now. Fldave
|
|
|
|
Post by dreamboatcruise on Feb 21, 2017 12:59:59 GMT -5
Nothing is going to move sales until we start a series of hard hitting advertisements. The pic of the kid that looks like a human pin cushion would be excellent. Look it is a new ballgame and consumers will have to drive demand the a'hole endo's will not, face it and move on. The ads will have to be made with the consumer in mind it should not be rocket science. Take the 30 million loan available and get started with the ads. Concentrate on selected areas and have sales dept follow up. The time is now. Management you are killing us using your old school methods they don't work get moving now. Fldave Hopefully it doesn't require some model of advertising that wouldn't get approved by FDA. According to management they already have variant ad concepts to discuss with FDA. Given that there have been no "old school" adverts to date, what makes you think the traditional model for drug ads allowed by FDA would not work as well for Afrezza as for other drugs? There were already a couple of concepts we've seen. The short videos with people inhaling at restaurant and outdoors, etc. Also, the "insulin" and "outsulin" characters. Could be something entirely different. I imagine they are in process of debating with FDA over what they can show regarding PK/PD and how to describe it. |
|
|
|
Post by fldave007 on Feb 21, 2017 13:38:54 GMT -5
Mannkind does not need to run ads by fda nor do they need approval by fda to begin advertising. Forget the fda run the ads management should know what they can or can't say.
|
|
|
|
Post by lojothehus on Feb 21, 2017 13:42:03 GMT -5
Hopefully it doesn't require some model of advertising that wouldn't get approved by FDA. According to management they already have variant ad concepts to discuss with FDA. Given that there have been no "old school" adverts to date, what makes you think the traditional model for drug ads allowed by FDA would not work as well for Afrezza as for other drugs? There were already a couple of concepts we've seen. The short videos with people inhaling at restaurant and outdoors, etc. Also, the "insulin" and "outsulin" characters. Could be something entirely different. I imagine they are in process of debating with FDA over what they can show regarding PK/PD and how to describe it. I believe that FLDAVE is talking moreso about MNKD following the traditional ways of releasing advertisements as opposed to the content of the advertisements and I would agree, MNKD needs to get into the ears of consumers as opposed to the Endos. Create the buzz, and the rest will follow. |
|
|
|
Post by prob0840 on Feb 21, 2017 14:53:58 GMT -5
I Agree 100%
|
|
|
|
Post by rockstarrick on Feb 21, 2017 17:52:18 GMT -5
Mannkind does not need to run ads by fda nor do they need approval by fda to begin advertising. Forget the fda run the ads management should know what they can or can't say. I wish you were correct, however the branch of the FDA that oversees drug Advertisements is The Office of Prescription Drug Promotions OPDP. To what extent they oversee is anybody's guess, but I believe anything like a TV Commercial would need the ok of that FDA branch. FYI Good Luck |
|
|
|
Post by bosephe on Feb 21, 2017 20:42:11 GMT -5
Putting aside advertising for Afrezza, Mannkind should also start to build up brand awareness. FDA approval is not need to promote the history of your company or the goals your company is trying to achieve. If people can get interested in the Mannkind the company maybe they will seek to learn more about the products Mannkind offers. $10 million a month is alot of money spent for there not to have been more advertising done. It is very bad that Afrezza currently is only a $10 million/year product (Mike's statement from last call). Prescription Drug Advertising: Questions and Answers |
|
|
|
Post by avi8torslc on Feb 21, 2017 20:50:33 GMT -5
Correct, FDA is currently reviewing the ad MNKD plans on running. I believe, final approval will depend on the new label.
|
|
|
|
Post by sportsrancho on Feb 21, 2017 21:11:31 GMT -5
Correct, FDA is currently reviewing the ad MNKD plans on running. I believe, final approval will depend on the new label. Great to see you avi8orsic! |
|
|
|
Post by mnholdem on Feb 21, 2017 21:24:56 GMT -5
It's been awhile since this username has appeared. You've made some good calls in the past avi8torslc including predicting this long PPS slide, but I must confess that I have always thought that following the "8" with a "t" in your username was redundant, a typographical stutter.   Welcome to ProBoards-MNKD.  |
|
|
|
Post by roguesuerte on Feb 21, 2017 21:34:26 GMT -5
Not ready to pat avi8tr on the back just yet. How has lending those shares to shorts been working out?
|
|
sparkrov
Newbie
Four year long
Posts: 15 
|
Post by sparkrov on Feb 21, 2017 23:35:44 GMT -5
Good to see you avi8orslc. You in slc?
|
|
|
|
Post by brotherm1 on Feb 22, 2017 0:12:51 GMT -5
Correct, FDA is currently reviewing the ad MNKD plans on running. I believe, final approval will depend on the new label. Which new label? When is it due out? What will it read? |
|
|
|
Post by mango on Feb 22, 2017 0:51:14 GMT -5
I posted about the FDA crack down on Sanofi's TV commercial recently. Obviously, if one is required to get the OK from the FDA prior to TV land then that is a load of BS because it simply is not true. The FDA has never said this. What is true, is that MannKind is once again taking the ethical route, and making sure what they have is OK with the FDA before they release it to the public. Last thing they want is being labeled a parasitic low-life like Sanofi.
|
|
|
|
Post by avi8torslc on Feb 22, 2017 11:58:16 GMT -5
Glenwild......just outside Park City
|
|
